In Chapter 5: Branching and Continuous Deployment, we explored how short-lived branches, and a centralized continuous deployment (CD) platform helped us accelerate delivery and reduce integration friction. These changes dramatically improved the flow of code to production-but to truly complete the DevOps feedback loop, we needed more.
In Chapter 4: Tracking What Matters – KPIs and Dashboards, we explored how visualizing workflow and defining the right KPIs helped us spot bottlenecks and align our teams around value delivery. With better visibility into our DevOps pipeline, we began to ask deeper questions-not just where the bottlenecks were, but why they were happening.
In our previous chapter, Designing for Testability: Breaking the Next Barrier, we explored how testability became a key focus after resolving initial bottlenecks in team setup and manual testing. That chapter marked a turning point in our DevOps transformation, as we shifted attention to deeper software design principles that enabled smoother, faster testing.
The year 2024 brought significant strides in regulatory submissions, but 2025 is set to revolutionize the field even further. For regulatory professionals, publishers, and life sciences companies, the upcoming year promises to bring unprecedented changes. With the integration of advanced technologies and a focus on global standards, the regulatory submission process is becoming more efficient and transparent.
In the Pharmaceutical Industry, Regulatory Documents are meticulously checked and consulted for the sake of public health care. Due to the sensitive nature of the data in such documents, managing and maintaining them in accordance with current compliance standards and laws is crucial; failure to do so incurs not just economic loss but also costs brand image and product launch delays. While regulatory documents today are in digital format, a centralized regulatory document management system can increase productivity and fasten compliance proceedings.
The life science industry plays a significant role in maintaining public health and medical emergencies which is why there are thorough checks on it and strict compliances to follow. Regulatory compliances in the life science industry must be followed to the letter, a mistake on any part will lead to delayed and ineffective medicines.
In today's rapidly evolving business landscape, organizations across life science industries face stringent Regulatory requirements. Compliance with these regulations is not only crucial for legal and ethical reasons but transforming end-to-end operations with a unified RIMS suite. With Regulatory Information Management System (RIMS), businesses now have a powerful tool to ensure compliance and streamline their Regulatory processes. In this blog, we will delve deeper into the role of Regulatory Information Management in unlocking the Regulatory landscape for compliance.
The process of submitting Regulatory documentation to Health Authorities can be complex and time-consuming. Many organizations partner with a vendor that offers a submission tool to ease this process. With so many options in the market, it can be difficult to know who the right strategic partner is for your submission requirements.
Regulatory submissions and publishing tasks have traditionally been laborious involving hours of manual efforts for formatting documents, generating agency-compliant PDFs, doing quality checks, assembling documents for submissions, etc. With the demanding timelines, life science companies always rush for timely submissions. Across the globe, Regulatory bodies are gearing up to adopt recent developments like eCTD v4.0 for dossier submissions, amendments, and other reports.
A multitude of challenges are faced by the Regulatory departments by the move from paper-based to eCTD submissions that continues around the world. Most of the life science companies are struggling hard to keep up with the USFDA standard in using eCTD format and meet the specified deadline. The compulsion of the eCTD format in the US and Canada has enhanced the submission procedure and made it easier by bridging the gap between the time and market which in turn is helping in minimizing expenses on electronic submissions to the pharmaceutical industries.